Why would they deliberately come up with a study design that harms their evaluation, trust, reputation, etc. and not one that optimized for best lab-condition results, like any sensible hair loss product company, for example?
I don't think any failure was deliberate. This is the cutting edge of cochlear medical research, and mistakes will happen. Perhaps they thought a little was good and more would be better? I am neither an employee or board member.
